Shared Target definition

Shared Target means (a) [***], (b) [***], (c) the [***], (d) [***] and (e) [***] [***] Target added as a Collaboration Target under the Collaboration Agreement.
Sample 1Sample 2Sample 3
Shared Target means (a) [***], (b) [***], (c) the [***] and (d) [***].
Sample 1Sample 2Sample 3
Shared Target shall have the meaning provided in Section 4.6.
Sample 1

Examples of Shared Target in a sentence

  • If NeoGenesis does not serve such notice within the specified period, such proposed Shared Target shall not be an Excluded Target and shall be deemed a Shared Target.

  • NeoGenesis will deliver a Final Target Report (as defined in ATTACHMENT A) with respect to the Screening Program work performed on each Shared Target.

  • If Roche bioscience elects to include such Target in the Research Collaboration, then it shall be treated as a Shared Target (as defined below).

  • Roche sites, other than Roche Bioscience, shall not be prohibited under this Agreement from conducting research directed against a Target included in the Research Collaboration (the "Shared Target") at any time if such research is conducted by such Roche site independently of any Target Information.

  • NeoGenesis will promptly notify Immusol if an Excluded Target that was excluded pursuant to Section 2.1 (b) does not become the subject of screening at NeoGenesis within said [*] period Immusol may have such Excluded Target deemed a Shared Target with notice to NeoGenesis.

  • Within [*] of each disclosure of a proposed Shared Target by Immusol, NeoGenesis shall notify Immusol in writing whether such proposed Shared Target is an Excluded Target (as defined below).

  • In addition, NeoGenesis will not screen any Shared Target with respect to which the parties have elected a Designated Shared Compound pursuant to Section 3.1.

  • NeoGenesis for a period of [*] following completion of all work by NeoGenesis under the Screening Program with respect to such Shared Target.

  • STAR = Shared Target and RewardsOutput = a result of the agency’s contribution, measured in terms of the agency business or processes, examples include hours worked, media plans, adaptation and GRPs.Outcome = a result of the agency’s contribution, measured in terms of the advertiser’s business metrics, examples include sales, store footfall, share price and market share.Bonus = Some form of additional payment on top of the agreed agency fee designed to reward good behavior, output or outcome.

  • Target and complete such screening obligations within [*] following the date of receipt of such Shared Target, unless the parties agree in writing to extend the period for performance.

Related to Shared Target

  • Collaboration Target means the Initial Collaboration Targets set forth on Exhibit F and any Additional Target or Substitute Target that is selected in accordance with Section 3.3 of this Agreement.

  • Soft Target means a target that will suffer minimum damage and cause minimum damage to the subject vehicle in the event of a collision.

  • KPI Target means the acceptable performance level for a KPI as set out in each KPI;

  • Collaboration Compound means any of the following: (a) FG-4592, (b) any HIF Compound (other than FG-4592) that is added to this Agreement pursuant to Section 3.6, and (c) any salts, esters, complexes, chelates, crystalline and amorphous morphic forms, pegylated forms, enantiomers (excluding regioisomers), prodrugs, solvates, metabolites and catabolites of any of the foregoing ((a) or (b)).

  • Development Candidate means a Compound that meets the Development Candidate Criteria for the initiation of a Development Program for the treatment of CF, and which is the subject of a notice from Vertex to CFFT that Vertex intends to commence formal pre-clinical development of the Compound in the Field pursuant to the provisions of Section 3.1 hereof.

  • Acquisition Target means any Person becoming a Subsidiary of the Company after the date hereof; any Person that is merged into or consolidated with the Company or any Subsidiary of the Company after the date hereof; or any Person with respect to which all or a substantial part of that Person’s assets are acquired by the Company or any Subsidiary of the Company after the date hereof.

  • Product Candidate means any pharmaceutical product developed, manufactured and/or tested by or on behalf of the Company that has not received a Regulatory Authorization for commercial distribution other than in connection with pre-clinical or clinical trials.

  • Second Target Distribution means $0.4375 per Unit per Quarter (or, with respect to the period commencing on the Closing Date and ending on September 30, 2005, it means the product of $0.4375 multiplied by a fraction of which the numerator is equal to the number of days in such period and of which the denominator is 92), subject to adjustment in accordance with Section 6.6 and Section 6.9.

  • Lead Compound means any compound of lead other than galena which, when treated in the manner described below, yields to an aqueous solution of hydrochloric acid a quantity soluble lead compound exceeding, when calculated as lead monoxide, five percent of the dry weight of the portion taken analysis.

  • Third Target Distribution means $0.5250 per Unit per Quarter (or, with respect to the period commencing on the Closing Date and ending on September 30, 2005, it means the product of $0.5250 multiplied by a fraction of which the numerator is equal to the number of days in such period and of which the denominator is 92), subject to adjustment in accordance with Section 6.6 and Section 6.9.

  • Antigen means a substance recognized by the body as being foreign; it results in the production of specific antibodies directed against it.

  • Development Milestone Event has the meaning set forth in Section 7.2.1.

  • Antibody means a molecule comprising or containing one or more immunoglobulin variable domains or any fragments, derivatives, variants or modifications thereof that bind to the same antigen.

  • Sanctioned Target means any target of Sanctions, including (i) persons on any list of targets identified or designated pursuant to any Sanctions, (ii) persons, countries, or territories that are the target of any territorial or country-based Sanctions program, (iii) persons that are a target of Sanctions due to their ownership or control by any Sanctioned Target(s), or (iv) persons otherwise a target of Sanctions, including vessels and aircraft, that are designated under any Sanctions program.

  • continuing candidate means any candidate not deemed to be elected, and not excluded,

  • Independent candidate means any candidate who claims not to be affiliated with a political party, and whose name has been certified on the office-type ballot at a general or special election through the filing of a statement of candidacy and nominating petition, as prescribed in section 3513.257 of the Revised Code.

  • EBITDA Target means the Company's projected earnings before interest, taxes, one-time transition expenses, non-cash compensation expense charges, depreciation and amortization, as contained in the Company's budget for the Applicable Period and which is approved by the Board (without reference to any adjustments or revision, upwards or downwards, to such projected earnings which are subsequently approved by the Board as part of any subsequent revision to such budget), and (ii) the term "Financial Results" shall mean the Company's EBITDA calculated by reference to the Company's financial statements for the Applicable Period as filed with the Securities and Exchange Commission (the "SEC").

  • Back-Up Compound means, with reference to any particular Development Candidate or Drug Product Candidate, a Compound which (a) has the same principal mode of action (i.e., Potentiator or Corrector) as that Development Candidate or Drug Product Candidate; and (b) was among the group of Compounds, identified by VERTEX as potential additional lead molecules having the same principal mode of action, from which the Development Candidate was selected.

  • Collaboration Product means a pharmaceutical product containing or comprising Compound in any dosage form alone, or in combination with, one or more other pharmaceutically active ingredients, and any and all Improvements thereto.

  • Valid write-in candidate means a candidate who has qualified as a write-in

  • First Liquidation Target Amount has the meaning assigned to such term in Section 6.1(c)(i)(D).

  • Licensed Compound means [***].

  • Replacement Candidate means any Candidate Introduced by the Agency to the Client to fill the Engagement following the Introduction of another Candidate whose Engagement either did not commence or was terminated during the first 12 weeks of the Engagement;

  • Development Milestone is defined in Section 5.3.

  • Collaboration Patent Rights means Patent Rights claiming Collaboration Know-How.

  • Program Patent Rights means any Patent Rights that contain one or more claims that cover Program Inventions.